Hielscher Ultrasonics
We will be glad to discuss your process.
Call us: +49 3328 437-420
Mail us: [email protected]

Ultrasonic topic: "Ultrasonic Processing in the Pharma Industry"

Power ultrasonics is a highly efficient and reliable tool for the production of vaccines, nano-formulated drugs and drug carriers (e.g. liposomes). Hielscher Ultrasonics’ lab, pilot and industrial systems produce pharma-grade micron- and nano-emulsions / -dispersions, liposomes as well as vaccines. Hielscher’s ultrasonic systems are equipped with CIP (clean-in-place) and SIP (sterilize-in-place) and guarantee thereby safe and efficient production according to pharmaceutical standards. All specific ultrasonic processes can be easily tested in lab or bench-top scale and then be linearly scaled up to industrial production.

UIP2000hdT - a 2000W high performance ultrasonicator with chemical batch reactor for intense processing.

Found 63 hits. Showing results 1 - 12.

High-intensity ultrasound enables reproducible nano-sizing and scalable encapsulation of semaglutide in liposomes for GLP-1 delivery.

Liposomal Semaglutide Could Be the Next Big Leap in GLP-1 Drug Delivery

Semaglutide and other GLP-1 peptides are among the most important modern therapeutics, but formulation scientists still face a fundamental barrier: peptide drugs are difficult to protect and deliver, especially by the oral route. Even approved oral semaglutide products show bioavailability below 1%, requiring high doses and complex formulation strategies.
A growing technical focus in pharmaceutical development is liposomal encapsulation combined with high-intensity ultrasonic processing. Liposomes can stabilize GLP-1 peptides and enable nano-scale carrier systems, while ultrasound provides reproducible nano-sizing and a scalable manufacturing pathway. Semaglutide is particularly compatible with lipid carriers because studies indicate it can associate with vesicle membranes via its lipid tail, supporting efficient loading into lipid bilayers.

https://www.hielscher.com/liposomal-semaglutide-could-be-the-next-big-leap-in-glp-1-drug-delivery.htm
Sonicator UP200St for the synthesis of biogenic medicines

Drug Manufacturing: Sonication Is Shaping the Future of Biogenic Medicines

This news article presents how sonication is transforming biogenic drug manufacturing: Ultrasonic processing is rapidly emerging as a key technology in the manufacturing of biogenic drugs, enabling greener, more efficient production of bioactive compounds and nanomedicines. New research demonstrates that ultrasound-assisted synthesis, using plant extracts such as broccoli, can produce highly stable, biologically active gold nanoparticles with antioxidant, wound-healing, and selective anticancer properties. High-performance probe-type sonicators, including industrial systems from Hielscher Ultrasonics, play a critical role by enhancing extraction efficiency, accelerating green nanoparticle synthesis, and ensuring precise process control. As demand grows for sustainable pharmaceutical manufacturing, sonication is positioning itself as a scalable, GMP-compatible platform for next-generation biogenic drugs.

https://www.hielscher.com/sonication-shapes-biogenic-medicines.htm

Request for more information

If you did not find what you were looking for, please contact us!

We will be glad to discuss your process.